Genomic and eco-epidemiological investigations in Uruguay reveal local Chikungunya virus transmission dynamics during its expansion across the Americas in 2023.

Chikungunya virus Uruguay genomic surveillance

Journal

medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986

Informations de publication

Date de publication:
20 Aug 2023
Historique:
pubmed: 30 8 2023
medline: 30 8 2023
entrez: 30 8 2023
Statut: epublish

Résumé

Uruguay experienced its first Chikungunya virus outbreak in 2023, resulting in a significant burden to its healthcare system. We conducted analysis based on real-time genomic surveillance (30 novel whole genomes) to offer timely insights into recent local transmission dynamics and eco-epidemiological factors behind its emergence and spread in the country.

Identifiants

pubmed: 37646000
doi: 10.1101/2023.08.17.23294156
pmc: PMC10462220
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NIAID NIH HHS
ID : U01 AI151698
Pays : United States

Déclaration de conflit d'intérêts

Conflict of interests The authors declare that there is no conflict of interests.

Auteurs

Analía Burgueño (A)

Laboratorio de Virus Emergentes/reemergentes. Unidad de Virología, Departamento de Laboratorios de Salud Pública.

Marta Giovanetti (M)

Instituto Rene Rachou, Fundação Oswaldo Cruz, Minas Gerais, Brazil.
Sciences and Technologies for Sustainable Development and One Health, Università Campus Bio-Medico di Roma, Italy.

Vagner Fonseca (V)

Department of Exact and Earth Sciences, University of the State of Bahia, Salvador, Brazil.
Coordenação de Vigilância, Preparação e Resposta à Emergências e Desastres (PHE), Organização Pan-Americana da Saúde / Organização Mundial da Saúde (OPAS/OMS), Brasilia DF, Brazil.

Noelia Morel (N)

Laboratorio de Virus Emergentes/reemergentes. Unidad de Virología, Departamento de Laboratorios de Salud Pública.

Mauricio Lima (M)

Laboratorio Central de Saúde Pública do Estado de Minas Gerais, Fundação Ezequiel Dias, Brazil.

Emerson Castro (E)

Laboratorio Central de Saúde Pública do Estado de Minas Gerais, Fundação Ezequiel Dias, Brazil.

Natália R Guimarães (NR)

Laboratorio Central de Saúde Pública do Estado de Minas Gerais, Fundação Ezequiel Dias, Brazil.

Felipe C M Iani (FCM)

Laboratorio Central de Saúde Pública do Estado de Minas Gerais, Fundação Ezequiel Dias, Brazil.

Victoria Bormida (V)

Laboratorio de Genómica Departamento de Laboratorios de Salud Pública, Uruguay.

Maria Noel Cortinas (MN)

Laboratorio de Genómica Departamento de Laboratorios de Salud Pública, Uruguay.

Viviana Ramas (V)

Laboratorio de Virus Respiratorios, Unidad de Virología. Departamento de Laboratorios de Salud Pública, Uruguay.

Leticia Coppola (L)

Laboratorio de Virus Respiratorios, Unidad de Virología. Departamento de Laboratorios de Salud Pública, Uruguay.

Ana I Bento (AI)

Pandemic Prevention Initiative, The Rockefeller Foundation, Washington DC, USA.

Leticia Franco (L)

Infectious Hazards Management, Health Emergencies Department (PHE), Pan American Health Organization / World Health Organization (PAHO/WHO), Washington DC, USA.

Jairo Mendez Rico (JM)

Infectious Hazards Management, Health Emergencies Department (PHE), Pan American Health Organization / World Health Organization (PAHO/WHO), Washington DC, USA.

José Lourenço (J)

BioISI (Biosystems and Integrative Sciences Institute), Faculdade de Ciências da Universidade de Lisboa.

Luiz Carlos Junior Alcantara (LCJ)

Instituto Rene Rachou, Fundação Oswaldo Cruz, Minas Gerais, Brazil.

Hector Chiparelli (H)

Unidad de Virología, Departamento de Laboratorios de Salud Pública.

Classifications MeSH